Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation.
Authors | |
Keywords | |
Abstract | Although genome-wide association studies have identified over 100 risk loci that explain ∼33% of familial risk for prostate cancer (PrCa), their functional effects on risk remain largely unknown. Here we use genotype data from 59,089 men of European and African American ancestries combined with cell-type-specific epigenetic data to build a genomic atlas of single-nucleotide polymorphism (SNP) heritability in PrCa. We find significant differences in heritability between variants in prostate-relevant epigenetic marks defined in normal versus tumour tissue as well as between tissue and cell lines. The majority of SNP heritability lies in regions marked by H3k27 acetylation in prostate adenoc7arcinoma cell line (LNCaP) or by DNaseI hypersensitive sites in cancer cell lines. We find a high degree of similarity between European and African American ancestries suggesting a similar genetic architecture from common variation underlying PrCa risk. Our findings showcase the power of integrating functional annotation with genetic data to understand the genetic basis of PrCa. |
Year of Publication | 2016
|
Journal | Nat Commun
|
Volume | 7
|
Pages | 10979
|
Date Published | 2016 Apr 07
|
ISSN | 2041-1723
|
URL | |
DOI | 10.1038/ncomms10979
|
PubMed ID | 27052111
|
PubMed Central ID | PMC4829663
|
Links | |
Grant list | CA54281 / CA / NCI NIH HHS / United States
CA128978 / CA / NCI NIH HHS / United States
R35 CA197449 / CA / NCI NIH HHS / United States
F32 GM106584 / GM / NIGMS NIH HHS / United States
U10 CA037429 / CA / NCI NIH HHS / United States
C522/A8649 / Cancer Research UK / United Kingdom
1 U19 CA148537-01 / CA / NCI NIH HHS / United States
75466 / Medical Research Council / United Kingdom
C5047/A10692 / Cancer Research UK / United Kingdom
U01 CA194393 / CA / NCI NIH HHS / United States
P30 CA68485 / CA / NCI NIH HHS / United States
UG1 CA189974 / CA / NCI NIH HHS / United States
C8197/A10123 / Cancer Research UK / United Kingdom
R01 CA092447 / CA / NCI NIH HHS / United States
U01 CA188392 / CA / NCI NIH HHS / United States
R01CA056678 / CA / NCI NIH HHS / United States
C490/A10124 / Cancer Research UK / United Kingdom
P30CA042014 / CA / NCI NIH HHS / United States
R01CA082664 / CA / NCI NIH HHS / United States
1U19 CA148065 / CA / NCI NIH HHS / United States
1U19 CA148537 / CA / NCI NIH HHS / United States
R01CA72818 / CA / NCI NIH HHS / United States
C8197/A10865 / Cancer Research UK / United Kingdom
R01 GM107427 / GM / NIGMS NIH HHS / United States
102215 / Wellcome Trust / United Kingdom
R01 CA056678 / CA / NCI NIH HHS / United States
076113 / Wellcome Trust / United Kingdom
CA63464 / CA / NCI NIH HHS / United States
C5047/A8384 / Cancer Research UK / United Kingdom
R01 CA193910 / CA / NCI NIH HHS / United States
C12292/A11174 / Cancer Research UK / United Kingdom
R01 CA128978 / CA / NCI NIH HHS / United States
G0500966 / Medical Research Council / United Kingdom
MC_PC_15018 / Medical Research Council / United Kingdom
R01 CA072818 / CA / NCI NIH HHS / United States
14136 / Cancer Research UK / United Kingdom
U19 CA148537 / CA / NCI NIH HHS / United States
G0401527 / Medical Research Council / United Kingdom
R01 CA063464 / CA / NCI NIH HHS / United States
R01 CA082664 / CA / NCI NIH HHS / United States
C5047/A7357 / Cancer Research UK / United Kingdom
R01 CA054281 / CA / NCI NIH HHS / United States
U01 CA063464 / CA / NCI NIH HHS / United States
P30 CA068485 / CA / NCI NIH HHS / United States
C5047/A3354 / Cancer Research UK / United Kingdom
R01 CA128813 / CA / NCI NIH HHS / United States
G0500966/75466 / Cancer Research UK / United Kingdom
1U19 CA148112 / CA / NCI NIH HHS / United States
R01 GM105857 / GM / NIGMS NIH HHS / United States
C1281/A12014 / Cancer Research UK / United Kingdom
U19 CA148112 / CA / NCI NIH HHS / United States
U01 CA098758 / CA / NCI NIH HHS / United States
C1287/A10710 / Cancer Research UK / United Kingdom
U19 CA148065 / CA / NCI NIH HHS / United States
10119 / Cancer Research UK / United Kingdom
R01CA128813 / CA / NCI NIH HHS / United States
C1287/A10118 / Cancer Research UK / United Kingdom
R01 MH101244 / MH / NIMH NIH HHS / United States
CA098758 / CA / NCI NIH HHS / United States
C16913/A6135 / Cancer Research UK / United Kingdom
R01CA092579 / CA / NCI NIH HHS / United States
R01 CA092579 / CA / NCI NIH HHS / United States
UM1 CA182883 / CA / NCI NIH HHS / United States
R01 CA188392 / CA / NCI NIH HHS / United States
U01 CA164973 / CA / NCI NIH HHS / United States
R37 CA054281 / CA / NCI NIH HHS / United States
P30 CA042014 / CA / NCI NIH HHS / United States
C5047/A15007 / Cancer Research UK / United Kingdom
10124 / Cancer Research UK / United Kingdom
|